OXi8007（Cat No.:I008523）is a selective inhibitor designed to target specific enzymes or signaling pathways involved in cancer progression and metastasis. It primarily acts on the oxidative stress pathways, helping to modulate cellular processes such as apoptosis, proliferation, and survival in tumor cells. By inhibiting these key molecular targets, OXi8007 shows potential in reducing tumor growth and enhancing the effectiveness of other cancer therapies. It is used in preclinical research to better understand the role of oxidative stress in cancer and to evaluate new therapeutic strategies aimed at targeting these pathways.